ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $57,000 | -61.7% | 19,873 | -43.4% | 0.01% | -65.0% |
| Q3 2021 | $149,000 | +9.6% | 35,086 | +36.4% | 0.02% | -56.5% |
| Q2 2021 | $136,000 | +40.2% | 25,718 | +23.8% | 0.05% | +48.4% |
| Q1 2021 | $97,000 | +40.6% | 20,778 | 0.0% | 0.03% | +55.0% |
| Q4 2020 | $69,000 | -59.2% | 20,778 | -59.3% | 0.02% | -63.0% |
| Q3 2020 | $169,000 | +21.6% | 51,028 | +24.0% | 0.05% | +14.9% |
| Q2 2020 | $139,000 | +13.0% | 41,148 | +28.6% | 0.05% | -9.6% |
| Q1 2020 | $123,000 | – | 32,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Managed Accounts LLC | 7,500 | $127,000 | 1.28% |
| DLD Asset Management, LP | 485,900 | $8,250,000 | 1.07% |
| DLD Asset Management, LP | 364,300 | $6,186,000 | 0.81% |
| Sio Capital Management, LLC | 70,300 | $1,193,000 | 0.57% |
| Granite Point Capital Management, L.P. | 135,200 | $2,294,000 | 0.57% |
| Perceptive Advisors | 100,000 | $10,164,000 | 0.51% |
| Worth Venture Partners, LLC | 61,600 | $394,000 | 0.34% |
| Worth Venture Partners, LLC | 46,600 | $229,000 | 0.20% |
| Fiduciary Trust Co International of Pennsylvania | 139,450 | $2,366,000 | 0.12% |
| ROTHSCHILD INVESTMENT LLC /IL | 57,070 | $968,000 | 0.11% |